Bankrupt Endo To Pay $465M To Resolve Opioid Claims

By Stewart Bishop · February 29, 2024, 12:20 PM EST

Drugmaker Endo International has agreed to pay as much as $465 million to resolve criminal and civil claims stemming from its sale and marketing of a powerful opioid, and will turn...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Endo International plc, et al.

Case Number

Court

New York Southern

Nature of Suit

Date Filed

August 16, 2022

Recent Articles By Stewart

November 07, 2024
Ex-Celsius CEO OK'd To Seek Testimony From Abroad
October 22, 2024
Real Estate Exec Guilty Of $77M WeWork Stock Fraud
October 21, 2024
$77M WeWork Bid Was Fraud 'From Beginning To End,' Jury Told
October 15, 2024
Exec's $77M WeWork Offer Was Stupid, Not Fraud, Jury Told
July 16, 2024
Platinum Co-Founder Dodges Prison For Bond Fraud Rap
May 24, 2024
Exiled Chinese Businessman Is No $1B Fraudster, Jury Told
March 19, 2024
Former Exec Set For Fall Trial In WeWork Stock Fraud Case
March 14, 2024
Ex-Real Estate Exec Accused Of $77M WeWork Stock Fraud
March 06, 2024
Ex-Stimwave CEO Found Guilty Of Healthcare Fraud
March 04, 2024
Trial Of Ex-Stimwave CEO Over Medical Device Nears End